- Home
- WERN vs BCRX Comparison
WERN vs BCRX Comparison
Compare WERN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WERN
- BCRX
- Stock Information
- Founded
- WERN 1956
- BCRX 1986
- Country
- WERN United States
- BCRX United States
- Employees
- WERN N/A
- BCRX 580
- Industry
- WERN Trucking Freight/Courier Services
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WERN Industrials
- BCRX Health Care
- Exchange
- WERN Nasdaq
- BCRX Nasdaq
- Market Cap
- WERN 1.8B
- BCRX 1.6B
- IPO Year
- WERN N/A
- BCRX 1994
- Fundamental
- Price
- WERN $23.42
- BCRX $8.53
- Analyst Decision
- WERN Hold
- BCRX Buy
- Analyst Count
- WERN 14
- BCRX 7
- Target Price
- WERN $34.57
- BCRX $16.29
- AVG Volume (30 Days)
- WERN 1.0M
- BCRX 3.5M
- Earning Date
- WERN 04-29-2025
- BCRX 05-05-2025
- Dividend Yield
- WERN 2.01%
- BCRX N/A
- EPS Growth
- WERN N/A
- BCRX N/A
- EPS
- WERN 0.55
- BCRX N/A
- Revenue
- WERN $3,030,258,000.00
- BCRX $450,712,000.00
- Revenue This Year
- WERN $3.79
- BCRX $27.64
- Revenue Next Year
- WERN $7.03
- BCRX $13.42
- P/E Ratio
- WERN $50.84
- BCRX N/A
- Revenue Growth
- WERN N/A
- BCRX 36.00
- 52 Week Low
- WERN $26.50
- BCRX $4.03
- 52 Week High
- WERN $42.48
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- WERN 27.72
- BCRX 66.23
- Support Level
- WERN $27.48
- BCRX $7.90
- Resistance Level
- WERN $28.26
- BCRX $8.62
- Average True Range (ATR)
- WERN 1.05
- BCRX 0.37
- MACD
- WERN -0.14
- BCRX 0.18
- Stochastic Oscillator
- WERN 7.55
- BCRX 97.69
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.